发明名称 Quinolizinone compound and use thereof as HIV integrase inhibitor
摘要 A pharmaceutical agent having an anti-HIV action, particularly, a pharmaceutical agent having an integrase inhibitory action, is provided. The present invention relates to a quinolizinone compound represented by the following formula [I] wherein each symbol is as defined in the specification, a pharmaceutically acceptable salt thereof, and an anti-HIV agent containing same as an active ingredient. The compound of the present invention has an HIV integrase inhibitory action and is useful as an anti-HIV agent for the prophylaxis or therapy of AIDS. Moreover, by a combined use with other anti-HIV agents such as protease inhibitors, reverse transcriptase inhibitors and the like, the compounds can become a more effective anti-HIV agent. Since the compound has a high inhibitory activity specific for integrases, the compound can provide a safe pharmaceutical agent for human with a fewer side effects.
申请公布号 US7745459(B2) 申请公布日期 2010.06.29
申请号 US20050230330 申请日期 2005.09.20
申请人 JAPAN TOBACCO INC. 发明人 SATOH MOTOHIDE;ARAMAKI HISATERU;NAKAMURA HIROSHI;INOUE MASAFUMI;KAWAKAMI HIROSHI;SHINKAI HISASHI;MATSUZAKI YUJI;YAMATAKA KAZUNOBU
分类号 A01N43/90;A61K31/44;C07D455/02 主分类号 A01N43/90
代理机构 代理人
主权项
地址